Vascular and Non-Vascular Stents Global Market - Forecast to 2021

  • ID: 3442306
  • Report
  • Region: Global
  • 348 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 6
Threats for the Stents Market Include Reduced Reimbursement, Alternative Procedures and Stringent Regulations for Stent Approval

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen Ag
  • Biotronik Se & Co. Kg
  • C.R.Bard Inc.
  • Cook Medical Inc
  • Medtronic Inc
  • MORE
Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation. Stents helps in improvement of the blood flow and prevents the blood vessels from bursting. The global stents market is segmented based on the types, applications, materials, coatings, and geography. Based on the types, the stents are divided into bare metal stents, drug-eluting stents and bio-resorbable stents.

By applications, the stents are divided into two segments as vascular and non-vascular stents. Vascular stents are further classified into coronary stents and peripheral stents. Peripheral stents are lower extremity & iliac stents, neurovascular stents and renal artery stents. Neurovascular stents sub segmented into carotid stents and intracranial stents. Non-vascular stents are divided into gastrointestinal, airway, urology and ophthalmology & other stents. Gastrointestinal stents are further segmented into pancreatic & biliary, esophageal, colorectal and duodenal stents.

Urology stents are further segmented into ureteral & urethral stents and prostate stents. Depending on its materials, there are Metals and Polymers. Metals are segmented as cobalt-chromium, nickel-titanium, platinum-chromium, stainless steel and others whereas polymers are segmented as durable polymer and bio-absorbable polymers. Based on the coating, there are coated stents and non-coated stents. Coated stents are further segmented into inorganic, polymer, polymer-free and other coated stents.

Polymer coated stents subdivided into non-biodegradable polymer and bio-degradable polymer coated stents. Geographical wise stents market segmented into North America, Europe, Asia-Pacific and Rest of the world (RoW). Among the stents by type, drug-eluting stents occupied the largest share of XX% in 2014 and bio-resorbable stent segment is the fastest growing segment at a CAGR of XX% from 2014 to 2021. Based on applications, vascular stents hold the major share of XX% in 2014 and which is again the fastest growing segment at CAGR of XX% from 2014 to 2021.

The report provides an in depth market analysis of the above mentioned segments across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen Ag
  • Biotronik Se & Co. Kg
  • C.R.Bard Inc.
  • Cook Medical Inc
  • Medtronic Inc
  • MORE
1 Executive Summary

2 Introduction
2.1 Key Take Aways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Crackdown And Data Triangulation
2.5.3 Secondary Sources
2.5.4 Primary Sources
2.5.5 Key Data Points From Secondary Sources
2.5.6 Key Data Points From Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Increasing Incidence Of Metabolic Diseases
3.3.1.2 Advancement In Technology
3.3.1.3 Rising Old Age Population
3.3.1.4 Preference For Minimally-Invasive Solutions & Rise In Vascular Procedures
3.3.1.5 Improving Modalities For Stent Placements
3.3.1.6 Stent Adoption In Emerging Regions
3.3.1.7 Wide Usage Of Stents
3.3.1.8 Improvements In Stent Designing
3.3.2 Restraints And Threats
3.3.2.1 Slashing Stent Prices
3.3.2.2 Side Effects Associated With Stents
3.3.2.3 Less Adoption & Long Term Efficacy Of Novel Technologies
3.3.2.4 Reduced Reimbursements
3.3.2.5 Alternative Procedures
3.3.2.6 Stringent Regulations
3.4 Porter’s Five Force Analysis
3.4.1 Threat Of New Entrants
3.4.2 Threat Of Substitutes
3.4.3 Bargaining Power Of Suppliers
3.4.4 Bargaining Power Of Buyers
3.4.5 Competitive Rivalry
3.5 Regulatory Affairs
3.5.1 U.S.
3.5.2 Europe
3.5.3 India
3.5.4 China
3.5.5 Japan
3.6 Market Share Analysis By Major Players
3.7 Reimbursement Scenario
3.7.1 Coronary Interventions
3.7.2 Carotid Artery Stenting
3.7.3 Peripheral Interventions
3.7.4 Biliary Stenting
3.7.5 Esophageal Stenting
3.7.6 Colonic And Duodenal Stenting
3.7.7 Tracheobronchial Stenting
3.7.8 Ureteral Stenting
3.7.9 Eye Stent
3.8 Upcoming Technologies
3.9 Supply Chain Analysis
3.10 Patent Analysis

4 Stents Market, By Types
4.1 Introduction
4.2 Bare Metal Stents
4.3 Drug Eluting Stents
4.4 Bio-Resorbable Stents (Bio-Absorbable Stents & Bio-Degradable Stents)
4.5 Others Stents

5 Stents Market, By Application
5.1 Introduction
5.2 Vascular Stents
5.2.1 Coronary Stents
5.2.2 Peripheral Stents
5.2.2.1 Lower Extremity And Iliac Stents
5.2.2.2 Neurovascular Stents
5.2.2.2.1 Carotid Stents
5.2.2.2.2 Intracranial Stents
5.2.2.3 Renal Artery Stents
5.3 Non-Vascular Stents
5.3.1 Gastrointestinal Stents
5.3.1.1 Pancreatic And Biliary Stents
5.3.1.2 Esophageal Stents
5.3.1.3 Colorectal Stents
5.3.1.4 Duodenal Stents
5.3.2 Airway Stents
5.3.3 Urology Stents
5.3.3.1 Ureteral Stents & Urethral Stents
5.3.3.2 Prostate Stents
5.3.4 Ophthalmology & Other Stents

6 Stents Market, By Materials
6.1 Introduction
6.2 Metal Stents
6.2.1 Cobalt-Chromium Stents
6.2.2 Nickel–Titanium Stents
6.2.3 Platinum-Chromium Stents
6.2.4 Stainless Steel Stents
6.2.5 Others
6.3 Polymers Stents
6.3.1 Durable Polymers Stents
6.3.2 Bio-Absorbable Polymer Stents

7 Stents Market, By Coatings
7.1 Introduction
7.2 Non-Coated Stents
7.3 Coated Stents
7.3.1 Inorganic Coatings
7.3.2 Polymer Coated Stents
7.3.2.1 Non-Biodegradable Polymer Coated Stents
7.3.2.2 Bio-Degradable Polymer Coated Stents
7.3.3 Polymer-Free Coated Stents
7.3.4 Other Coated Stents

8 Regional Market Analysis
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Rest Of The World (Row)

9 Company Developments
9.1 Introduction
9.1.1 Approval As A Major Growth Strategy Of Active Pharmaceutical Ingredients Market Players
9.2 Approval
9.3 New Product Launch
9.4 Agreements, Partnerships, Collaborations & Joint Ventures
9.5 Other Developments
9.6 Mergers & Aqusitions
9.7 Business Expansion

10 Major Player Profiles
10.1 Abbott Laboratories
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Key Developments
10.1.5 Business Strategy
10.1.6 Swot Analysis
10.2 B. Braun Melsungen Ag
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Key Developments
10.2.5 Business Strategy
10.2.6 Swot Analysis
10.3 Biosensors International Group
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Key Developments
10.3.5 Business Strategy
10.3.6 Swot Analysis
10.4 Biotronik Se & Co. Kg
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Key Developments
10.4.5 Business Strategy
10.4.6 Swot Analysis
10.5 Boston Scientific Corpoartion
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Key Developments
10.5.5 Business Strategy
10.5.6 Swot Analysis
10.6 C.R.Bard Inc.
10.6.1 Overview
10.6.2 Financials
10.6.3 Product Portfolio
10.6.4 Key Developments
10.6.5 Business Strategy
10.6.6 Swot Analysis
10.7 Cook Medical Inc
10.7.1 Overview
10.7.2 Financials
10.7.3 Product Portfolio
10.7.4 Key Developments
10.7.5 Business Strategy
10.7.6 Swot Analysis
10.8 Johnson & Johnson (Cordis Corporation)
10.8.1 Overview
10.8.2 Financials
10.8.3 Product Portfolio
10.8.4 Key Developments
10.8.5 Business Strategy
10.8.6 Swot Analysis
10.9 Medtronic Inc
10.9.1 Overview
10.9.2 Financials
10.9.3 Product Portfolio
10.9.4 Key Developments
10.9.5 Business Strategy
10.9.6 Swot Analysis
10.10 Microport Scientific Corporation
10.10.1 Overview
10.10.2 Financials
10.10.3 Product Portfolio
10.10.4 Key Developments
10.10.5 Business Strategy
10.10.6 Swot Analysis
10.11 Olympus Corporation
10.11.1 Overview
10.11.2 Financials
10.11.3 Product Portfolio
10.11.4 Key Developments
10.11.5 Business Strategy
10.11.6 Swot Analysis
10.12 Terumo Corporation
10.12.1 Overview
10.12.2 Financials
10.12.3 Product Portfolio
10.12.4 Key Developments
10.12.5 Business Strategy
10.12.6 Swot Analysis

List Of Tables

Table 1 Global Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 2 Global Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 3 Global Stents Market Revenue, By Application, (2013-2021) ($Mn)
Table 4 Global Stent Market Revenue, By Material Type, (2013-2021) ($Mn)
Table 5 Global Stent Market Revenue, By Coating Type, (2013-2021) ($Mn)
Table 6 Global Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 7 Global Stents Procedural Volume, By Type, (2013-2021) (No’s)
Table 8 Global Bare Metal Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 9 Global Bare Metal Stents Procedural Volume, By Region, (2013-2021) (No’s)
Table 10 Global Drug Eluting Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 11 Global Drug Eluting Stents Procedural Volume, By Region, (2013-2021) (No’s)
Table 12 Global Bio-Resorbable Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 13 Global Bio-Resorbable Stents Procedural Volume, By Region, (2013-2021) (No’s)
Table 14 Global Others Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 15 Global Stents Market Revenue, By Application, (2013-2021) ($Mn)
Table 16 Global Vascular Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 17 Global Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 18 Global Coronary Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 19 Global Peripheral Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 20 Global Peripheral Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 21 Global Lower Extremity & Iliac Artery Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 22 Global Neurovascular Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 23 Global Neurovascular Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 24 Global Carotid Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 25 Global Intracranial Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 26 Global Renal Artery Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 27 Global Non-Vascular Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 28 Global Non-Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 29 Global Gastrointestinal Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 30 Global Gastrointestinal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 31 Global Pancreatic & Biliary Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 32 Global Esophageal Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 33 Global Colorectal Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 34 Global Duodenal Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 35 Global Airway Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 36 Global Urology Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 37 Global Urology Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 38 Global Ureteral & Urethral Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 39 Global Prostate Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 40 Global Ophthalmology & Other Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 41 Global Stent Market Revenue, By Material Type, (2013-2021) ($Mn)
Table 42 Global Metal Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 43 Global Metal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 44 Global Cobalt-Chromium Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 45 Global Nickel-Titanium Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 46 Global Platinum-Chromium Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 47 Global Stainless Steel Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 48 Global Other Metal Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 49 Global Polymer Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 50 Global Polymer Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 51 Global Durable Polymer Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 52 Global Bio-Absorbable Polymer Stents Market Revenue, By Region, (2013-2021) ($Mn)
Table 53 Global Stent Market Revenue, By Coating Type, (2013-2021) ($Mn)
Table 54 Global Non-Coated Stent Market Revenue, By Region, (2013-2021) ($Mn)
Table 55 Global Coated Stent Market Revenue, By Region, (2013-2021) ($Mn)
Table 56 Global Coated Stent Market Revenue, By Type, (2013-2021) ($Mn)
Table 57 Global Inorganic Coated Stent Market Revenue, By Region, (2013-2021) ($Mn)
Table 58 Global Polymer Coated Stent Market Revenue, By Region, (2013-2021) ($Mn)
Table 59 Global Polymer Coated Market Revenue, By Type, (2013-2021) ($Mn)
Table 60 Global Non-Biodegradable Polymer Coated Stent Market Revenue, By Region, (2013-2021) ($Mn)
Table 61 Global Bio-Degradable Polymer Coated Stent Market Revenue, By Region, (2013-2021) ($Mn)
Table 62 Global Polymer-Free Coated Stent Market Revenue, By Region, (2013-2021) ($Mn)
Table 63 Global Other Coated Stent Market Revenue, By Region, (2013-2021) ($Mn)
Table 64 North American Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 65 North American Stents Market Revenue, By Application, (2013-2021) ($Mn)
Table 66 North American Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 67 North American Peripheral Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 68 North American Neurovascular Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 69 North American Non-Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 70 North American Gastrointestinal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 71 North American Urology Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 72 North American Stent Market Revenue, By Material Type, (2013-2021) ($Mn)
Table 73 North American Metal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 74 North American Polymer Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 75 North American Stent Market Revenue, By Coating Type, (2013-2021) ($Mn)
Table 76 North American Stent Coated Market Revenue, By Type, (2013-2021) ($Mn)
Table 77 North American Polymer Coated Market Revenue, By Type, (2013-2021) ($Mn)
Table 78 European Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 79 European Stents Market Revenue, By Application, (2013-2021) ($Mn)
Table 80 European Vascular Stents Market Revenue By Segment, (2013-2021) ($Mn)
Table 81 European Peripheral Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 82 European Neurovascular Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 83 European Non-Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 84 European Gastrointestinal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 85 European Urology Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 86 European Stent Market Revenue, By Material Type, (2013-2021) ($Mn)
Table 87 European Metal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 88 European Polymer Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 89 European Stent Market Revenue, By Coating Type, (2013-2021) ($Mn)
Table 90 European Stent Coated Market Revenue, By Type, (2013-2021) ($Mn)
Table 91 European Polymer Coated Market Revenue, By Type, (2013-2021) ($Mn)
Table 92 Asia-Pacific Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 93 Asia-Pacific Stents Market Revenue, By Application, (2013-2021) ($Mn)
Table 94 Asia-Pacific Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 95 Asia-Pacific Peripheral Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 96 Asia-Pacific Neurovascular Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 97 Asia-Pacific Non-Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 98 Asia-Pacific Gastrointestinal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 99 Asia-Pacific Urology Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 100 Asia-Pacific Stent Market Revenue, By Material Type, (2013-2021) ($Mn)
Table 101 Asia-Pacific Metal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 102 Asia-Pacific Polymer Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 103 Asia-Pacific Stent Market Revenue, By Coating Type, (2013-2021) ($Mn)
Table 104 Asia-Pacific Coated Stent Market Revenue, By Type, (2013-2021) ($Mn)
Table 105 Asia-Pacific Polymer Coated Market Revenue, By Type, (2013-2021) ($Mn)
Table 106 Row Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 107 Row Stents Market Revenue, By Application, (2013-2021) ($Mn)
Table 108 Row Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 109 Row Peripheral Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 110 Row Neurovascular Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 111 Row Non-Vascular Stents Market Revenue, By Segment, (2013-2021) ($Mn)
Table 112 Row Gastrointestinal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 113 Row Urology Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 114 Row Stent Market Revenue, By Material Type, (2013-2021) ($Mn)
Table 115 Row Metal Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 116 Row Polymer Stents Market Revenue, By Type, (2013-2021) ($Mn)
Table 117 Row Stent Market Revenue, By Coating Type, (2013-2021) ($Mn)Mn)
Table 118 Row Coated Stent Market Revenue, By Type, (2013-2021) ($Mn)
Table 119 Row Polymer Coated Market Revenue, By Type, (2013-2021) ($Mn)
Table 120 Approval (2013-2015)
Table 121 New Products Launch (2013-2015)
Table 122 Agreements, Partnerships, Collaborations & Joint Ventures (2013-2015)
Table 123 Other Developments (2013-2015)
Table 124 Mergers & Acquisition (2013-2015)
Table 125 Business Expansion (2013-2015)
Table 126 Abbott Laboratories: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 127 Abbott Laboratories: Total Revenue By Segments, (2012-2014) ($Mn)
Table 128 Abbott Laboratories: Total Revenue By Geography, (2012-2014) ($Mn)
Table 129 B.Braun Melsungen Ag: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 130 B.Braun Melsungen Ag: Total Revenue, By Segments, (2012-2014) ($Mn)
Table 131 B.Braun Melsungen Ag: Total Revenue, By Geography, (2012-2014) ($Mn)
Table 132 Biosensors International Group: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 133 Biosensors International Group: Total Revenue, By Segment, (2012-2014) ($Mn)
Table 134 Biosensors International Group: Total Revenue, By Geography, (2012-2014) ($Mn)
Table 135 Boston Scientific Corporation: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 136 Boston Scientific Corporation: Total Revenue, By Segment, (2012-14) ($Mn)
Table 137 Boston Scientific Corporation: Cardiovascular Business Revenue, By Segmnet, (2012-2014) ($Mn)
Table 138 Boston Scientific Corporation: Total Revenue, By Geography, (2012-2014) ($Mn)
Table 139 C.R.Bard Inc: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 140 C.R.Bard Inc: Total Revenue, By Segment, (2012-14) ($Mn)
Table 141 Johnson & Johnson: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 142 Johnson & Johnson: Total Revenue, By Segment, (2012-2014) ($Mn)
Table 143 Johnson & Johnson: Total Revenue, By Geography,(2012-2014) ($Mn)
Table 144 Medtronic Inc.: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 145 Medtronic Inc.: Total Revenue, By Segment, (2012-2014) ($Mn)
Table 146 Medtronic Inc.: Total Revenue, By Geography, (2012-2014) ($Mn)
Table 147 Microport Scientific Corporation : Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 148 Microport Scientific Corporation:Total Revenue, By Segment, (2012-2014) ($Mn)
Table 149 Microport Scientific Corporation : Total Revenue, By Geography, (2012-2014) ($Mn)
Table 150 Olympus Corporation : Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 151 Olympus Corporation : Total Revenue, By Segment, (2012-2014) ($Mn)
Table 152 Olympus Corporation : Total Revenue, By Region, (2012-2014) ($Mn)
Table 153 Terumo Corporation: Total Revenue And R&D Expenses, (2011-2013) ($Mn)
Table 154 Terumo Corporation: Total Revenue, By Segment, (2011-13) ($Mn)
Table 155 Terumo Corporation: Total Revenue, By Geography, (2011-2013) ($Mn)

List Of Figures

Figure 1 Global Stents Market Share, By Geography, (2013-2021) ($Mn)
Figure 2 Research Methodology: Stents Market
Figure 3 Stents Market: Top-Down And Bottom-Up Approach
Figure 4 Stents Market: Forecasting Model
Figure 5 Stents Market: Market Crachdown And Data Triangulation
Figure 6 Stents Market: Market Segmentation
Figure 7 Market Dynamics
Figure 8 Stents Market: Porter’s Analysis
Figure 9 Global Stents Market Share Analysis, By Key Players, 2014
Figure 10 Stents Devices Market: Supply Chain Analysis
Figure 11 Stents Market:Patent Filing By Major Players, (2010-2015)
Figure 12 Global Stents Market Revenue, By Type, (2014 V’s 2021) ($Mn)
Figure 13 Global Stents Market Revenue, By Application, (2013 - 2021) ($Mn)
Figure 14 Global Vascular Stents Market Revenue, By Segment, (2014 V’s 2021) ($Mn)
Figure 15 Global Non-Vascular Stents Market Revenue, By Segment, (2014 V’s 2021) ($Mn)
Figure 16 Global Stents Market Revenue, By Material, (2014 V’s 2021) ($Mn)
Figure 17 Global Metal Stents Market Revenue, By Type, (2014 V’s 2021) ($Mn)
Figure 18 Global Polymer Stents Market Revenue, By Type, (2014 V’s 2021) ($Mn)
Figure 19 Global Stents Market Revenue, By Coating, (2014 V’s 2021) ($Mn)
Figure 20 Global Coated Stents Market Revenue, By Type, (2014 V’s 2021) ($Mn)
Figure 21 Global Stents Market Revenue, By Region, (2013- 2021) ($Mn)
Figure 22 North American Stents Market Outlook, By Types, Applications, Materials & Coatings, (2014 V’s 2021) ($Mn)
Figure 23 European Stents Market Outlook, By Types, Applications, Materials & Coatings, (2014 V’s 2021) ($Mn)
Figure 24 Asia-Pacific Stents Market Outlook, By Types, Applications, Materials & Coatings, (2014 V’s 2021) ($Mn)
Figure 25 Row Stents Market Outlook, By Types, Applications, Materials & Coatings, (2014 V’s 2021) ($Mn)
Figure 26 Key Growth Strategies (2013-2015)
Figure 27 Swot Analysis: Abbott Laboratories
Figure 28 Swot Analysis: B.Braun Melsungen Ag
Figure 29 Swot Analysis: Biosensors International Group
Figure 30 Swot Analysis: Biotronik Se & Co. Kg
Figure 31 Swot Analysis: Boston Scientific Corporation
Figure 32 Swot Analysis: C.R.Bard Inc.
Figure 33 Swot Analysis: Cook Medical Inc.
Figure 34 Swot Analysis: Johnson & Johnson
Figure 35 Swot Analysis: Medtronic Inc
Figure 36 Swot Analysis: Microport Scientific Corporation
Figure 37 Swot Analysis: Olympus Corporation
Figure 38 Swot Analysis: Terumo Corporation
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen Ag
  • Biotronik Se & Co. Kg
  • C.R.Bard Inc.
  • Cook Medical Inc
  • Medtronic Inc
  • MORE
Based on materials, metals occupied the largest share of 90.3% in 2014 and polymers segment is the fastest growing segment at a CAGR of XX% from 2014 to 2021. In case of coatings, coated stents occupied the largest share of XX% in 2014 and which is also expected to grow at highest CAGR of XX% from 2014 to 2021. Similarly by geographies, North America holds the major share of 42.3% among the geographies due to the introduction of new technologies by leading players, growing awareness and increased prevalence of arterial diseases and Asia is the fastest growing segment at a CAGR of XX% from 2014 to 2021 due to government initiatives for modernization of healthcare infrastructure, and increasing focus of both international and domestic players on the stents market.

The stents market is expected to grow steadily from 2014 to 2021 at CAGR of XX%. The factors driving the growth of this market are increasing incidence of metabolic diseases, advancement in technology, raising old age population, preference for minimally invasive solution and rise in vascular procedures. In addition to this, improving modalities of stent placements, stent adaptation in emerging regions, wide usage of stents and improvement in stent design and customized stents are some of the opportunities that are propelling the growth of the market. However, slashing prices of stents, side effects associated with stents and less adoption and long term efficacy of novel technologies are hampering the growth of the market.

The threats for the stents market include reduced reimbursement, alternative procedures and stringent regulations for stent approval and medical tax. The global stents market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares.

Note: Product cover images may vary from those shown
5 of 6
- Abbott Laboratories
- B. Braun Melsungen Ag
- Biosensors International Group
- Biotronik Se & Co. Kg
- Boston Scientific Corpoartion
- C.R.Bard Inc.
- Cook Medical Inc
- Johnson & Johnson (Cordis Corporation)
- Medtronic Inc
- Microport Scientific Corporation
- Olympus Corporation
- Terumo Corporation
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll